SEC Form 4 · accession 0001209191-17-050554
ACURA PHARMACEUTICALS, INC · ACUR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Albert W Brzeczko
Officer — VP Technical Affairs - APT
Period of report
Aug 25, 2017
Accepted (ET)
Aug 29, 2017 · 4:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000786947
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 25, 2017 | P | 1,000 | $0.48 | A | 6,200 | D | |
| Common Stock | Aug 25, 2017 | P | 1,000 | $0.48 | A | 7,200 | D | |
| Common Stock | Aug 25, 2017 | P | 1,000 | $0.48 | A | 8,200 | D | |
| Common Stock | Aug 25, 2017 | P | 1,800 | $0.48 | A | 10,000 | D | |
| Common Stock | Aug 28, 2017 | P | 2,000 | $0.4546 | A | 12,000 | D | |
| Common Stock | Aug 29, 2017 | P | 2,000 | $0.4699 | A | 14,000 | D | |
| Common Stock | Aug 29, 2017 | P | 1,000 | $0.47 | A | 15,000 | D | |
| Common Stock | Aug 29, 2017 | P | 1,000 | $0.47 | A | 16,000 | D |
Table II — derivative securities
No Table II lines on this filing.